Recombinant multi-species KDELR1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine KDELR1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
Retention of resident soluble proteins in the lumen of the endoplasmic reticulum (ER) is achieved in both yeast and animal cells by their continual retrieval from the cis-Golgi, or a pre-Golgi compartment. Sorting of these proteins is dependent on a C-terminal tetrapeptide signal, usually lys-asp-glu-leu (KDEL) in animal cells, and his-asp-glu-leu (HDEL) in S. cerevisiae. This process is mediated by a receptor that recognizes, and binds the tetrapeptide-containing protein, and returns it to the ER. In yeast, the sorting receptor encoded by a single gene, ERD2, which is a seven-transmembrane protein. Unlike yeast, several human homologs of the ERD2 gene, constituting the KDEL receptor gene family, have been described. The protein encoded by this gene was the first member of the family to be identified, and it encodes a protein structurally and functionally similar to the yeast ERD2 gene product. [provided by RefSeq, Jul 2008]
The Alternative Names of target: KDELR1,ER lumen protein-retaining receptor 1,KDEL endoplasmic reticulum protein retention receptor 1 (KDEL receptor 1), Putative MAPK-activating protein PM23,ERD2,HDEL,PM23,ERD2.1
Go
to KDELR1 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-IP1041-Ab-1/ GM-Tg-hg-IP1041-Ab-2 | Human KDELR1 protein | Human |
GM-Tg-rg-IP1041-Ab-1/ GM-Tg-rg-IP1041-Ab-2 | Rat KDELR1 protein | Rat |
GM-Tg-mg-IP1041-Ab-1/ GM-Tg-mg-IP1041-Ab-2 | Mouse KDELR1 protein | Mouse |
GM-Tg-cynog-IP1041-Ab-1/ GM-Tg-cynog-IP1041-Ab-2 | Cynomolgus/Rhesus macaque KDELR1 monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-IP1041-Ab-1/ GM-Tg-felg-IP1041-Ab-2 | Feline KDELR1 protein | Feline |
GM-Tg-cang-IP1041-Ab-1/ GM-Tg-cang-IP1041-Ab-2 | Canine KDELR1 protein | Canine |
GM-Tg-bovg-IP1041-Ab-1/ GM-Tg-bovg-IP1041-Ab-2 | Bovine KDELR1 protein | Bovine |
GM-Tg-equg-IP1041-Ab-1/ GM-Tg-equg-IP1041-Ab-2 | Equine KDELR1 protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. |
GM-Tg-hg-IP1041-Ab-1/ GM-Tg-hg-IP1041-Ab-2;
GM-Tg-rg-IP1041-Ab-1/ GM-Tg-rg-IP1041-Ab-2;
GM-Tg-mg-IP1041-Ab-1/ GM-Tg-mg-IP1041-Ab-2; GM-Tg-cynog-IP1041-Ab-1/ GM-Tg-cynog-IP1041-Ab-2; GM-Tg-felg-IP1041-Ab-1/ GM-Tg-felg-IP1041-Ab-2; GM-Tg-cang-IP1041-Ab-1/ GM-Tg-cang-IP1041-Ab-2; GM-Tg-bovg-IP1041-Ab-1/ GM-Tg-bovg-IP1041-Ab-2; GM-Tg-equg-IP1041-Ab-1/ GM-Tg-equg-IP1041-Ab-2 |
Products Name | KDELR1 protein |
Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
Target Name | KDELR1 |
Protein Sub-location | Introcelluar Protein |
Isotypes | Recombinant protein |
Expression platform | Mammalian cell |
Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
Tag | His |
Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine KDELR1 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab
GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.